Vital Farms (NASDAQ:VITL) Posts Earnings Results, Meets Estimates

Vital Farms (NASDAQ:VITL) released its quarterly earnings data on Thursday. The company reported ($0.47) EPS for the quarter, hitting analysts’ consensus estimates of ($0.47), FiscalAI reports. Vital Farms had a net margin of 6.10% and a return on equity of 14.47%. The company had revenue of $166.03 million during the quarter, compared to the consensus estimate of $160.24 million. During the same period last year, the firm earned $0.36 EPS. The firm’s revenue for the quarter was down 10.2% compared to the same quarter last year.

Here are the key takeaways from Vital Farms’ conference call:

• Q2 results deteriorated sharply: net revenue fell 10.1% to $166 million and adjusted EBITDA was a $26.6 million loss, driven by excess egg supply, $19.5 million in breaker-sale impacts, and other discrete costs.
• Management said the turnaround is gaining traction, citing price-gap reductions, a more than 200-basis-point year-over-year increase in retail dollar share, and a 12.5% sequential rise in shell-egg units per store per week by mid-July.
• Distribution expansion remains a major growth driver, with 2026 average TDPs expected at 150–160 and fourth-quarter TDPs projected at 170–175, supported by new placements across mass, grocery, and natural channels.
• Vital Farms reaffirmed full-year guidance of $775 million–$800 million in net revenue and $0 million–$10 million in adjusted EBITDA, expecting second-half improvement from lower breaker costs, increased retail volume, and $6 million–$7 million in annualized SG&A savings.
• The company strengthened liquidity with a new $125 million term loan and $60 million asset-based lending facility, but terminated its share-repurchase program and paused Vital Crossroads construction to prioritize cash preservation.

Vital Farms Price Performance

NASDAQ VITL traded up $0.27 on Thursday, hitting $12.51. 3,146,974 shares of the company were exchanged, compared to its average volume of 1,465,600. Vital Farms has a 1-year low of $7.95 and a 1-year high of $53.13. The firm has a 50 day moving average of $11.83 and a two-hundred day moving average of $15.60. The company has a current ratio of 1.77, a quick ratio of 1.00 and a debt-to-equity ratio of 0.01. The company has a market cap of $536.05 million, a P/E ratio of 12.03 and a beta of 1.07.

Analyst Upgrades and Downgrades

Several research firms recently issued reports on VITL. Mizuho set a $20.00 price target on shares of Vital Farms in a research report on Monday, May 4th. Benchmark raised shares of Vital Farms from a “hold” rating to a “buy” rating in a report on Thursday. DA Davidson raised shares of Vital Farms to a “hold” rating in a report on Monday, July 6th. Craig Hallum cut shares of Vital Farms from a “buy” rating to a “hold” rating and set a $10.00 price objective on the stock. in a research note on Friday, May 8th. Finally, Stifel Nicolaus reaffirmed a “hold” rating and set a $10.00 price objective (down from $34.00) on shares of Vital Farms in a report on Friday, May 8th. Six equities research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $24.08.

Insider Activity at Vital Farms

In related news, insider Stephanie Coon bought 5,895 shares of the company’s stock in a transaction on Friday, May 15th. The stock was bought at an average cost of $8.42 per share, with a total value of $49,635.90. Following the completion of the purchase, the insider owned 62,314 shares in the company, valued at approximately $524,683.88. The trade was a 10.45% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Glenda J. Flanagan bought 6,100 shares of Vital Farms stock in a transaction dated Monday, May 18th. The shares were bought at an average price of $8.33 per share, for a total transaction of $50,813.00. Following the completion of the transaction, the director directly owned 37,498 shares of the company’s stock, valued at $312,358.34. This represents a 19.43% increase in their position. The SEC filing for this purchase provides additional information. Over the last 90 days, insiders have bought 38,700 shares of company stock worth $320,864. 3.90% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of VITL. Wasatch Advisors LP raised its holdings in Vital Farms by 80.2% during the 2nd quarter. Wasatch Advisors LP now owns 2,074,803 shares of the company’s stock worth $79,921,000 after purchasing an additional 923,507 shares during the last quarter. Balyasny Asset Management L.P. grew its position in shares of Vital Farms by 466.5% during the 4th quarter. Balyasny Asset Management L.P. now owns 503,894 shares of the company’s stock worth $16,094,000 after buying an additional 641,394 shares during the period. Two Sigma Investments LP grew its position in shares of Vital Farms by 159.0% during the 3rd quarter. Two Sigma Investments LP now owns 840,508 shares of the company’s stock worth $34,587,000 after buying an additional 516,037 shares during the period. State Street Corp raised its stake in shares of Vital Farms by 64.7% during the fourth quarter. State Street Corp now owns 1,293,788 shares of the company’s stock worth $41,324,000 after buying an additional 508,222 shares during the last quarter. Finally, Trexquant Investment LP raised its stake in shares of Vital Farms by 1,548.9% during the fourth quarter. Trexquant Investment LP now owns 448,770 shares of the company’s stock worth $14,334,000 after buying an additional 421,554 shares during the last quarter. Institutional investors own 98.59% of the company’s stock.

Key Vital Farms News

Here are the key news stories impacting Vital Farms this week:

• Positive Sentiment: Analyst upgrade: Benchmark Co. upgraded Vital Farms from “hold” to “buy,” which may improve investor sentiment and suggests the firm sees upside in the shares following their recent weakness. Finviz
• Positive Sentiment: Revenue topped expectations: Vital Farms reported second-quarter revenue of $166.03 million, above the $160.24 million analyst consensus. The company also issued fiscal 2026 revenue guidance of $775 million to $800 million, broadly in line with the $778.3 million consensus and described as optimistic in market coverage. Vital Farms Reports Second Quarter 2026 Financial Results
• Neutral Sentiment: Quarterly earnings were near expectations: Vital Farms posted a loss of $0.47 per share, meeting the company-reported consensus estimate of $0.47. Zacks characterized the result as a slight miss versus its $0.46 loss estimate. Vital Farms Q2 Earnings Report
• Negative Sentiment: Sales and profitability deteriorated: Quarterly revenue declined 10.2% from the prior-year period, while the company swung from earnings of $0.36 per share to a $0.47 per-share loss. The results may temper enthusiasm despite the revenue beat. Vital Farms Earnings Results
• Negative Sentiment: New debt financing: Silver Point Capital led a $125 million term-loan financing for Vital Farms. The funding may provide liquidity and support operations or growth, but it also increases debt obligations and could weigh on investors focused on balance-sheet risk. Silver Point Leads $125 Million Term Loan Financing

About Vital Farms

Vital Farms, traded on the NASDAQ under the symbol VITL, is a U.S.-based food company specializing in pasture-raised egg and dairy products. The company partners with a network of family farms across the United States to produce eggs, butter and related items under a certified humane, pasture-centric farming model. Vital Farms’ supply chain emphasizes animal welfare, environmental stewardship and transparent sourcing, appealing to consumers seeking ethically produced, high-quality ingredients.

Founded in 2007 and headquartered in Austin, Texas, Vital Farms began by marketing pasture-raised eggs to health- and ethically minded shoppers.